Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2025-12-26 @ 11:14 AM
NCT ID:
NCT06439628
Eligibility Criteria:
Inclusion Criteria:
* Participants must meet all of the following inclusion criteria to be eligible for inclusion in the study:
1. Male or female participants aged ≥ 18 years-old
2. Primary diagnosis of migraine according to ICHD-3
3. Migraine attacks present for more than 1 year
4. Rimegepant is prescribed for the acute treatment of migraine by physician
5. Written informed consent must be obtained before participant is enrolled
Exclusion Criteria:
* Participants meeting any of the following criteria will not be included in the study:
1. Severe impairment of speech, vision, memory or cognition, or other factors that affect communication and ability to complete questionnaires and follow-up
2. Lack of necessary digital tools to complete questionnaires on a digital platform
3. History of hypersensitivity reaction to Rimegepant or to any of its components
4. Participants with severe hepatic impairment or end-stage renal disease
5. Any situation that the investigator believes may affect the patient's participation in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06439628
Study Brief:
Protocol Section:
NCT06439628